Mr Filipe Correia Martins

Filipe Correia Martins is a clinical associate professor and a consultant surgeon in gynaecological oncology. He graduated from medical school from the University of Coimbra (Portugal) in 2006. He did a MSc in experimental pathology prior to being selected for the competitive PhD Gulbenkian Programme for Advanced Medical Education (2008-2012). His PhD work in breast cancer genetic was supervised by Prof. Kornelia Polyak (Dana-Farber Cancer Institute/Harvard Medical School). He then moved to Cambridge, where he did his clinical training whilst doing post-doctoral research as a NIHR-funded Academic Clinical Fellow (2013-2015), an Academic Clinical Lecturer (Experimental Medicine Initiative; University of Cambridge/Astrazeneca 2016-2020) and a Crick Postdoctoral clinical fellow (2018-2019), under the supervision of Prof. James Brenton and Prof. Charles Swanton, respectively. Dr. Correia Martins is the RCS/BGCS Subspecialty Lead for Gynaecological Oncology, the chief investigator for the TARGET-FAL01 study and the co-lead for the NEMO Consortium.